195 related articles for article (PubMed ID: 12435521)
61. Mycophenolate mofetil for Crohn's disease?
Lowry PW; Sandborn WJ; Lipsky JJ
Lancet; 1999 Jul; 354(9172):3-4. PubMed ID: 10406354
[No Abstract] [Full Text] [Related]
62. Mycophenolate mofetil: new applications for this immunosuppressant.
Moder KG
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
[TBL] [Abstract][Full Text] [Related]
63. Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan and Mowel after liver transplantation.
Vollmar J; Bellmann MC; Darstein F; Hoppe-Lotichius M; Mittler J; Heise M; Rüttger B; Weyer V; Zimmermann A; Lang H; Galle PR; Zimmermann T
Drug Des Devel Ther; 2015; 9():6139-49. PubMed ID: 26604701
[TBL] [Abstract][Full Text] [Related]
64. Mycophenolate mofetil-based immunosuppressive minimization and withdrawal strategies in renal transplantation: possible risks and benefits.
Meier-Kriesche HU
Curr Opin Nephrol Hypertens; 2006 Jun; 15 Suppl 1():S1-5. PubMed ID: 16829733
[TBL] [Abstract][Full Text] [Related]
65. Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil.
Barten MJ; Rahmel A; Richter M; Tarnok A; Bartsch P; Boeger M; Gehlhaar P; Dhein S; Mohr FW; Gummert JF
Transplant Proc; 2002 Sep; 34(6):2372-3. PubMed ID: 12270442
[No Abstract] [Full Text] [Related]
66. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
67. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
Lanata CM; Mahmood T; Fine DM; Petri M
Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
[TBL] [Abstract][Full Text] [Related]
68. Mycophenolate in dermatology.
Liu V; Mackool BT
J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
[TBL] [Abstract][Full Text] [Related]
69. Mycophenolate mofetil in pancreas transplantation.
Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
[TBL] [Abstract][Full Text] [Related]
70. Dapsone: unapproved uses or indications.
Wolf R; Tüzün B; Tüzün Y
Clin Dermatol; 2000; 18(1):37-53. PubMed ID: 10701085
[No Abstract] [Full Text] [Related]
71. [Topical skin therapy with glucocorticoids--therapeutic index].
Luger T; Loske KD; Elsner P; Kapp A; Kerscher M; Korting HC; Krutmann J; Niedner R; Röcken M; Ruzicka T; Schwarz T
J Dtsch Dermatol Ges; 2004 Jul; 2(7):629-34. PubMed ID: 16281629
[No Abstract] [Full Text] [Related]
72. Successful reversal of acute vascular rejection in a renal allograft with combined mycophenolate mofetil and tacrolimus as primary immunotherapy.
Ahsan N; Holman MJ; Katz DA; Abendroth CS; Yang HC
Clin Transplant; 1997 Apr; 11(2):94-7. PubMed ID: 9113443
[TBL] [Abstract][Full Text] [Related]
73. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
[TBL] [Abstract][Full Text] [Related]
74. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
[TBL] [Abstract][Full Text] [Related]
75. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results.
Chamienia A; Dębska-Ślizień A; Król E; Biedunkiewicz B; Rutkowski B
Transplant Proc; 2014 Oct; 46(8):2714-8. PubMed ID: 25380901
[TBL] [Abstract][Full Text] [Related]
76. First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation.
Kahl A; Bechstein WO; Platz K; Müller A; Berweck S; Venz S; Neuhaus P; Frei U
Transplant Proc; 1998 Mar; 30(2):505-6. PubMed ID: 9532149
[No Abstract] [Full Text] [Related]
77. Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant.
Opelz G; Döhler B
Transplantation; 2008 Aug; 86(3):371-6. PubMed ID: 18698238
[TBL] [Abstract][Full Text] [Related]
78. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
[TBL] [Abstract][Full Text] [Related]
79. Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study.
Squifflet JP; Vanrenterghem Y; van Hooff JP; Salmela K; Rigotti P;
Transplant Proc; 2002 Aug; 34(5):1584-6. PubMed ID: 12176495
[No Abstract] [Full Text] [Related]
80. Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation.
Busque S; Shoker A; Landsberg D; McAlister V; Halloran P; Shapiro J; Peets J; Schulz M
Transplant Proc; 2001; 33(1-2):1266-7. PubMed ID: 11267285
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
